Ozempic Dominates Obesity Treatment with Two Million New Users in Q1 2026

Ozempic Dominates Obesity Treatment with Two Million New Users in Q1 2026

In the past week, discussions around Ozempic and weight loss have heated up among listeners tuning into health news. According to Bloomberg News on March 30, 2026, new data from the Food and Drug Administration shows Ozempic, the popular semaglutide injection from Novo Nordisk, continues to dominate prescriptions for obesity treatment, with over two million new users reported in the first quarter alone. This surge follows clinical trials confirming sustained weight loss of up to twenty percent in participants over two years, though side effects like nausea remain common.

Oprah Winfrey weighed in during her April 1, 2026, interview on CBS This Morning, sharing her personal journey with Ozempic. She described losing forty pounds since starting the drug last fall, emphasizing how it curbs appetite without the crash diets of her past. Oprah stressed to listeners that Ozempic is a tool, not a magic fix, and paired it with therapy and exercise for mental health benefits. People magazine reported her comments sparked thousands of social media posts, with many praising her transparency on body image struggles.

Yet, concerns linger. The Wall Street Journal noted on April 2, 2026, that supply shortages persist due to demand outpacing production, forcing some doctors to ration doses. A study in The Lancet, published March 31, 2026, highlighted rare but serious risks like pancreatitis in long-term users, prompting calls for closer monitoring.

Experts like Dr. Jason Fung, quoted in Healthline on April 3, 2026, advise listeners considering Ozempic to consult physicians, as it mimics the GLP-one hormone to slow digestion and signal fullness. While effective, lifestyle changes amplify results.

Thanks for tuning in, listeners, please come back next week for more. Thanks for listening, please subscribe, and remember, this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai.

Some great Deals https://amzn.to/49SJ3Qs

For more check out http://www.quietplease.ai

This content was created in partnership and with the help of Artificial Intelligence AI

Episoder(71)

Florida Law Enforcement Warns Against AI Deepfake Crime Videos as Pranks Waste Critical Resources

Florida Law Enforcement Warns Against AI Deepfake Crime Videos as Pranks Waste Critical Resources

In the past week, law enforcement in Florida has issued urgent warnings about a dangerous new prank involving artificial intelligence-generated fake crime videos. According to the Orange County Sherif...

8 Apr 3min

Ozempic Policy Debate Heats Up in Minnesota as Celebrity Health Rumors Swirl Around Weight Loss Drugs

Ozempic Policy Debate Heats Up in Minnesota as Celebrity Health Rumors Swirl Around Weight Loss Drugs

In the past week, discussions around Ozempic and weight loss drugs have intensified, blending policy debates with celebrity health rumors. Minnesota lawmakers grappled with costs in the House Health F...

1 Apr 2min

Ozempic Shows Mental Health Benefits but Poses Risks if Stopped, New Research Warns

Ozempic Shows Mental Health Benefits but Poses Risks if Stopped, New Research Warns

Recent studies from the past week highlight new insights into Ozempic and similar GLP-1 medications for weight loss. Researchers from the University of Eastern Finland, Karolinska Institutet in Stockh...

28 Mar 2min

GLP-1 Drugs Like Ozempic Show Promise for Weight Maintenance After Stopping But Heart Risks Emerge

GLP-1 Drugs Like Ozempic Show Promise for Weight Maintenance After Stopping But Heart Risks Emerge

A new study from the Cleveland Clinic, released this week, reveals that stopping weight-loss drugs like Ozempic and Mounjaro does not always lead to the rapid weight regain seen in earlier trials. Res...

25 Mar 2min

Cleveland Clinic Study Shows Less Weight Regain After Stopping Ozempic and Wegovy Than Expected

Cleveland Clinic Study Shows Less Weight Regain After Stopping Ozempic and Wegovy Than Expected

Recent research from Cleveland Clinic is challenging what many people thought they knew about stopping weight loss medications like Ozempic and Wegovy. A new study published in the journal Diabetes, O...

21 Mar 3min

Ozempic Weight Loss Study Shows 75 Percent Regain Within 15 Months Without Lifestyle Changes

Ozempic Weight Loss Study Shows 75 Percent Regain Within 15 Months Without Lifestyle Changes

A recent analysis from the University of Cambridge, published in eClinicalMedicine, reveals that people stopping Ozempic-like drugs such as semaglutide and tirzepatide retain about twenty-five percent...

18 Mar 2min

GLP-1 Drug Switching Common in First Year, Study Shows Better Long-Term Weight Loss Success

GLP-1 Drug Switching Common in First Year, Study Shows Better Long-Term Weight Loss Success

A new study from UT Southwestern Medical Center, reported by HealthDay News on March 12, reveals that people often switch between GLP-1 weight-loss drugs like Ozempic and Zepbound within the first yea...

14 Mar 2min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
aftenpodden-usa
popradet
stopp-verden
forklart
det-store-bildet
lydartikler-fra-aftenposten
rss-ness
rss-gukild-johaug
fotballpodden-2
dine-penger-pengeradet
hanna-de-heldige
aftenbla-bla
nokon-ma-ga
rss-dannet-uten-piano
rss-penger-polser-og-politikk
rss-utenrikskomiteen-med-bogen-og-grasvik
e24-podden
bt-dokumentar-2